Treating life-threatening bleedings development of recombinant coagulation factor VIIa / Ulla K.E. Hedner, MD, PhD, Emeritus Professor of Hemostasis Research, University of Lund, Lund, Sweden.

Contents Classical bleeding disease -- My encounter with hemophilia -- The first years at novo nordisk -- The development of recombinant FVIIa -- The futher use and development of rFVIIa -- Legal issues regarding the use of rFVIIa in hemophilia patients with inhibitors -- Treatment with rFVIIa in Malmö --Mechanism of action and dosage -- The continued development of rFVIIa during the 2000s -- Three different descriptions of how rFVIIa was developed -- Some final remarks.
Bibliography noteIncludes bibliographical references and index.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2017946970
ISBN9780128124390 (pbk.)
ISBN0128124393 (pbk.)

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available